MCN Resources

To help raise awareness of influenza vaccination recommendations and the importance of continuing vaccination efforts throughout November and beyond, the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), the National Influenza Vaccine Summit, partners and stakeholders will be announcing a National Influenza Vaccination Week (NIVW) from Monday, November 27th through Sunday, December 3rd, 2006.

A listing of farmworker organizations and agencies that are seeking volunteers and interns to support their work.

Findings from the 2005 NIS include nationwide increases in coverage with >=3 and >=4 doses of pneumococcal conjugate vaccine (PCV) and continued high levels of coverage for the other recommended vaccines and vaccine series. In addition, no racial/ethnic disparities in coverage estimates were observed in the 4:3:1:3:3:1§ vaccine series, the recommended series for children aged 19-35 months that includes DTP/DT/DTaP; poliovirus vaccine; measles, mumps, and rubella vaccine (MMR); Haemophilus influenzae type b vaccine; hepatitis B vaccine; and varicella vaccine.

The NIP website recently posted information about the 2006 National Adult Immunization Awareness Week (NAIAW), which is scheduled for September 24-30. This year marks the 19th consecutive observance of NAIAW. In addition, NIP posted a link to the printable version of the NAIAW 2006 Campaign Kit, which was created by the National Foundation for Infectious Diseases (NFID). To access the kit from the NFID website, go to: www.nfid.org/pdf/publications/naiaw06.pdf

Following the recent Food and Drug Administration (FDA) approval of a vaccine targeting cervical cancer, Women in Government, a national, bi-partisan, non-profit organization representing women state legislators, today recommended that all girls entering middle school be vaccinated against the human papillomavirus (HPV), the cause of cervical cancer. The recommendation is part of the group's new policy recommendations for the HPV vaccine's implementation in the states.

On September 5, CDC released an interim VIS for human papillomavirus (HPV) vaccine. The final VIS will be developed after ACIP recommendations are published in MMWR and the vaccine is covered by the Vaccine Injury Compensation Program.

In June 2005 and June 2006, the ACIP made policy changes for use of live, attenuated varicella containing vaccines for prevention of varicella.

On August 14, CDC posted provisional recommendations for use of HPV vaccine. Routine vaccination with three doses of quadrivalent HPV vaccine is recommended for females 11–12 years of age. The vaccination series can be started in females as young as 9 years of age.